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Background: Mycobacterium tuberculosis differs from most pathogens in its ability to multiply inside monocytes
and to persist during long periods of time within granuloma in a status of latency. A class of proteins called
mycobacterial histone-like proteins has been associated with regulation of replication and latency, but their precise
role in the infection process has yet to be uncovered. Our study aimed at defining the impact of the histone-like
protein MDP1 from M. bovis BCG (mycobacterial DNA-binding protein 1, corresponding to Rv2986c from
M. tuberculosis) on early steps of infection.
Results: Previously, a BCG (Bacillus Calmette Guérin) strain had been generated by antisense-technique exhibiting
reduced MDP1 expression. This strain was now used to analyse the impact of reduced amount of MDP1 on the
interaction with human blood monocytes, macrophage lines and PBMC (peripheral blood mononuclear cells).
MDP1 was revealed to be required for growth at acidic pH and for intracellular replication in human blood
monocytes. Down-regulation of MDP1 resulted in reduced secretion of the cytokine IL-1β by infected human
PBMC. In addition, a reduction of MDP1 expression had a major impact on the formation of fused multi-nucleated
macrophages. In monocyte preparations from human blood as well as in human and mouse macrophage cell lines,
both the percentage of multi-nucleated cells and the number of nuclei per cell were much enhanced when the
monocytes were infected with BCG expressing less MDP1.
Conclusion: MDP1 from M. bovis BCG affects the growth at acidic pH and the intracellular replication in human
monocytes. It furthermore affects cytokine secretion by host cells, and the formation of fused multi-nucleated
macrophages. Our results suggest an important role of MDP1 in persistent infection.
Keywords: Mycobacterium, Tuberculosis, Mycobacterial DNA-binding protein 1, MDP1, DNA-binding protein,
Histone-like protein, Latency, Granuloma, Virulence, Host interactionBackground
Mycobacterium tuberculosis is one of the leading causes
of death due to a single infectious agent. Its success is
based on perfect adaptation to the human host and the
conditions prevailing in infected cells and tissues such as
hypoxia, nutrient starvation, low pH and the presence of
antimicrobial substances. By adapting their gene expres-
sion, growth and metabolism to these environmental
conditions, the bacteria are able to persist over long per-
iods of time inside immune cells within granuloma in a* Correspondence: Lewina@rki.de
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reproduction in any medium, provided the orlatent state until possible reactivation and outbreak of
disease. To be able to combat the disease, it is necessary
to understand the molecular mechanisms regulating
mycobacterial intracellular persistence, latency and
reactivation.
A class of proteins implicated in regulating latency are
the mycobacterial histone-like proteins (Hlp) [1]. Hlp have
been identified in pathogenic as well as environmental
mycobacteria [2,3]. Proteins belonging to this class have
been given different designations in different mycobacterial
species such as HLPMt or HupB in M. tuberculosis [3,4],
MDP1 (mycobacterial DNA-binding protein 1) in Mycobac-
terium bovis BCG [5], Hlp in Mycobacterium smegmatis [2]
and ML-LBP21 in Mycobacterium leprae [6]. They arel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gous to eukaryotic histone H1 and an N-terminal region
similar to HU from Escherichia coli [3,5]. Hlp expression is
developmentally regulated and up-regulation was observed
in dormant M. smegmatis [2] and stationary cultures from
M. bovis BCG [5]. It is an immunogenic protein detectable
in tuberculosis patients [7]. Hlp are nucleoid-associated
proteins [8], but have also been found to be surface-
exposed [5,6,9,10]. They bind to DNA [3,5] preferring AT-
rich DNA-sequences [11] as well as to laminin, hyaluronic
acid, heparin, and chondroitin sulphate [5,6,12]. The data
available so far portray Hlp as multi-faceted proteins, and
accordingly a variety of possible functions have been
ascribed to Hlp. Hlp were suggested to impact DNA pack-
aging, protection of DNA from enzymatic and non-
enzymatic strand breakage [11], gene regulation [1], nucleic
acid metabolism, non-homologous-end-joining repair [13],
adaptation to hypoxic conditions [2], induction of dor-
mancy [2], adaptation to cold shock [14], adhesion
[6,9,12,15-17], cell wall biogenesis [10] and regulation of
growth rate [1,5,10]. A role in transition to the non-
culturable state and in resuscitation from the non-
culturable state was shown in M. smegmatis [18]. Whiteford
et al. [19] investigated the growth characteristics of an M.
smegmatis with a deletion of hlp. They found that the mu-
tant showed less aggregation in broth cultures. Further-
more, they observed an increased sensitivity towards
Isoniazid. The M. smegmatis mutant also was affected in
UV-resistance and resistance towards freezing/thawing.
Takatsuka et al. [20] have recently shown that Hlp has a
similar activity to ferritin superfamily proteins and protects
DNA by ferroxidase activity. It furthermore captures iron
molecules and functions as iron storage protein.
Approaches to elucidate the functions of Hlp by muta-
genesis did not always confirm the expected roles of Hlp
[2,15,21]. Our own attempts to generate a MDP1 deletion
mutant had failed. Furthermore and in line with our own
experience, Sassetti et al. [22] had shown by high density
mutagenesis that the gene Rv2986c from M. tuberculosis,
which is homologous to MDP1 from BCG, is required for
optimal growth of M. tuberculosis. We therefore followed
the strategy to analyse Hlp functions by down-regulation
of Hlp expression by antisense-technique. Advantages of
this technique are the possibility to analyse essential genes
and to repress genes present in several copies. In myco-
bacteria the antisense-technique has been applied to
down-regulate ahpC from M. bovis [23], dnaA from M.
smegmatis [24], FAP-P from M. avium subsp. paratuber-
culosis [25] or pknF from M. tuberculosis [26]. In a previ-
ous study we described the generation of the antisense-
strain M. bovis BCG (pAS-MDP1) which carries the plas-
mid pAS-MDP1 causing a reduction of MDP1 expression
in BCG by about 50% [27]. We analysed BCG (pAS-
MDP1) with respect to general growth characteristics.The down-regulated BCG grew faster in broth culture and
achieved a higher cell mass in the stationary phase. Simi-
larly, growth was enhanced in human and murine
macrophage-like cell lines. A further important finding
was the reduced protein synthesis occurring under hyp-
oxic conditions [27]. These findings support a role of
MDP1 in growth regulation of M. bovis BCG. Since we
postulate the growth rate to be of major importance for
virulence and intracellular persistence, we now investi-
gated the role of MDP1 for the interaction of BCG with
host cells during early phases of infection.
Results
MDP1 is essential for adaptation of BCG to low pH
Bacteria present in activated macrophages have to face
low phagosomal pH conditions. We therefore tested the
ability to adapt to low pH of M. bovis BCG, containing
the empty cloning vector pMV261 [BCG (pMV261)],
and of M. bovis BCG with the MDP1-antisense-plasmid
pAS-MDP1 [BCG (pAS-MDP1)], by comparing the
growth without and with pH stress. Bacteria were grown
to optical density (OD) 3 [600 nm], then diluted and
inoculated into fresh Middlebrook 7H9 (Mb) /Oleic
Acid-Dextrose-Catalase (OADC) medium adjusted to
pH 7 and pH 5.3, respectively, and growth was moni-
tored by measurement of OD and ATP content. As
shown in Figure 1A, BCG (pAS-MDP1) reached a
slightly higher OD in medium with neutral pH in com-
parison to BCG (pMV261) and also a higher maximal
amount of ATP (Figure 1B). In medium adjusted to pH
5.3 only BCG (pMV261) was able to grow (Figure 1C, D).
The growth rate of BCG (pMV261) in low pH medium
was slightly below its growth rate in neutral medium if
determined by OD measurement. In medium adjusted
to pH 7 BCG (pMV261) grew to an OD of 3.6 after
42 days (Figure 1A). In contrast the OD of cultures
grown in medium adjusted to pH 5.3 was only 2.9
after 42 days (Figure 1C). The strain BCG (pAS-
MDP1) behaved very differently at low pH. It was not
able to adapt to the low pH conditions and showed no
growth at pH 5.3 (Figure 1C, D).
MDP1 plays a role in persistence of BCG in human blood
monocytes
The alveolar macrophages represent the first line of de-
fence the mycobacteria have to overcome in order to es-
tablish a successful long-lasting infection. We therefore
analysed the ability of our BCG strains to survive in
human blood monocytes. Monocytes were infected with
BCG (pMV261) and BCG (pAS-MDP1) grown to OD 2
at an MOI of 1 and the amount of intracellular bacteria
was quantified one, two, three and five days after infec-
tion by quantitative real-time PCR. As shown in Figure 2,
the BCG with the empty plasmid started multiplying
Figure 1 Growth in acidic medium. BCG (pMV261) and BCG (pAS-MDP1) were grown in Mb/OADC medium adjusted to pH 7 (A, B) or pH 5.3
(C, D), respectively, and the growth of the mycobacteria was monitored by measurement of the OD [600 nm] (A, C) and the amount of ATP in
the cultures (B, D). The ATP amount was measured using a luminescence assay and is reported as relative light units (RLU). Each value represents
the mean of three cultures with the standard deviation. The results of a paired student’s t test are shown by asterisks (*: P < 0.05, **: P < 0.01).
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more cells of BCG (pMV261) were present than after
the initial infection period of four hours. In contrast, the
BCG containing the MDP1-antisense-plasmid stayedFigure 2 Intracellular survival. Human blood monocytes were
infected with BCG (pMV261) and BCG (pAS-MDP1) at an MOI of 1,
and the amount of intracellular bacteria in the cell lysates was
determined by real-time PCR. The values represent the mean of
three wells with the standard deviation. The results of a paired
student’s t test are represented by asterisks (*: P < 0.05, **: P < 0.01).relatively constant throughout the whole experiment. It
only showed little growth between days two and three
and otherwise decreased in number. MDP1 thus plays
an important role for survival and growth of BCG in
monocytes.MDP1 affects the cytokine secretion of infected PBMC
The immune response against mycobacterial infections is
coordinated by cytokines, and we therefore investigated
cytokine expression of human PBMC induced by infection
with BCG (pMV261) compared to BCG (pAS-MDP1). The
PBMC were infected with the two strains at an MOI of 1
and the amount of selected pro- and anti-inflammatory
cytokines (IFN-γ, TNF-α, IL-1β, IL-10) present in the super-
natants was measured after 24 hours. Negative controls
consisted of uninfected cells, and positive controls were
activated with LPS and IFN-γ. All cytokines were induced
upon activation with LPS/IFN-γ and upon infection with
mycobacteria (data not shown). As shown in Figure 3, the
down-regulation of MDP1 resulted in a decreased secretion
of IL-1β (n=7 donors), IFN-γ (n= 5), and IL-10 (n=5).
However, if means from all donors were calculated, only
the reduction in IL-1β secretion was statistically significant
(Figure 3A). The amount of IL-1β in supernatants of PBMC
Figure 3 Cytokine secretion by human PBMC. Human PBMC were infected with BCG (pMV261) and BCG (pAS-MDP1) at an MOI of 1, and the
amount of IL-1β (A), IFN-γ (B), TNF-α (C) and IL-10 (D) in the supernatants was quantified by ELISA 24 hours after infection. The values were
referred to the amount of cytokines induced by BCG (pMV261), which were set to 100%. The columns represent the mean of at least five
independent experiments (different donors) with the standard deviation. The results of an unpaired student’s t test showing the significance of
different expressions in PBMC infected with BCG (pMV261) and BCG (pAS-MDP1) are represented by asterisks (**: P < 0.01).
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supernatants of PBMC infected with BCG (pMV261). No
effect was observed on the secretion of TNF-α (Figure 3C).
MDP1 influences the rate of macrophage fusion
Since the fusion of macrophages and the formation of
multi-nucleated cells is one of the hallmarks of chronic
infections associated with granuloma formation [28] we
were interested in analysing the effect of MDP1 on
macrophage fusion. To this end we infected the mouse
macrophage line RAW264.7, the human macrophage
line Mono Mac 6 (MM6) and monocytes isolated from
human blood with BCG (pMV261) and BCG (pAS-
MDP1). Uninfected cells served as negative controls and
cells activated with LPS and IFN-γ as positive controls.
At different times after infection (up to 11 days) the cells
were stained with Diff Quick and the nuclei per cell
were counted to determine the fusion index (FI). Ziehl-
Neelsen staining was performed to confirm uptake of
mycobacteria by multi-nucleated cells (data not shown).
The time course of fusion of human blood monocytes
is shown in Figure 4. In uninfected human blood
monocytes, very few multi-nucleated cells were present
only after four days (Figure 4A, B), while the infected
cells and the positive controls had fused already at day
three (Figure 4D, G, K). At day four, clear differences
were visible between the different experimental settings
(Figure 4B, E, H, L). The uninfected control had formed
only very few fused cells with only three nuclei
(Figure 4B), while the infected cells had produced more
fused macrophages with a much higher number of nu-
clei (Figure 4E, H). In Figure 4E [infection with BCG
(pMV261)], for example, up to nine nuclei per cell
are visible, and in Figure 4H [infection with BCG
(pAS-MDP1)] up to 12 nuclei per cell can becounted. At this time point the LPS/IFN-γ-stimulated
blood monocytes had also formed fused cells, but
additionally cell aggregates were formed, which were
not visible in the other experimental settings
(Figure 4L). Eleven days after infection cells had
enlarged, and with the exception of the negative con-
trol the fusion process had proceeded. The fusion in-
dexes of blood monocytes 11 days after infection are
shown in Table 1. The BCG strain down-regulated
with respect to MDP1 expression depicted a fusion
index of 15.1% which was 1.7 times higher than the fu-
sion index induced by BCG with the empty vector
pMV261 (8.7%). Especially at early time points most of
the nuclei were arranged in a circle at the outer rim of
the monocytes and depicted the morphology typical of
the Langhans cells present in tuberculous lesions [29].
The fusion process in the macrophage cell lines
RAW264.7 and MM6 was followed over a shorter time of
up to five days, because of experimental limitations due to
multiplication of the cells. The results obtained with pri-
mary human blood monocytes could be confirmed by the
use of the two cell lines. As shown in Table 1 RAW264.7
infected with BCG (pAS-MDP1) had formed 5.1 times
more multi-nucleated cells after five days than RAW264.7
infected with BCG (pMV261). The cell line MM6 pre-
sented 3.2 times more multi-nucleated cells after infection
with BCG (pAS-MDP1) than after infection with the
reference strain three days after infection (Table 1). The
different cell types varied with respect to maximal fusion
indexes reached. Upon infection with BCG (pAS-MDP1),
for example, RAW264.7 achieved the highest fusion index
with 27.2% followed by human blood monocytes with
15.1%. The lowest fusion activity was observed with MM6
cells that only reached a fusion index of 7.4% (Table 1).




















Figure 4 Formation of multi-nucleated cells by human blood monocytes. Monocytes were isolated from human blood and infected with
BCG (pMV261) (D, E, F) or BCG (pAS-MDP1) (G, H, I), respectively. Uninfected cells (A, B, C) served as negative control. Blood monocytes activated
with LPS and IFN-γ are shown in K, L, M. The cells were stained with Diff-Quick after three (A, D, G, K), four (B, E, H, L) and 11 (C, F, I, M) days.
Micrographs were taken with a magnification of 200 ×. Arrows mark multi-nucleated cells.
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(Figure 5). The morphology typical of Langhans cells char-
acterised by nuclei arranged in a circle along of the per-
iphery of the cell was only present in human blood
monocytes (Figure 5A). RAW264.7 cells were shaped
more irregularly, and the nuclei were concentrated in the
central part of the cells (Figure 5C). Multi-nucleated
MM6 cells were strongly enlarged, round, and the nuclei
were spread relatively evenly across the cells (Figure 5B).
The fusion process then was analysed in-depth by cal-
culating the fusion indexes with respect to the number
of nuclei per cell. Figure 6 is a graphic illustration of the
distribution of the fusion indexes in the cell line
RAW264.7. The uninfected cells generated multi-
nucleated cells up to only seven nuclei per cell. Up to
eight nuclei per fused cell were present in RAW264.7
infected with BCG (pMV261). Much more fused cellsTable 1 Fusion index of different macrophages/monocytes af
Cell type MOIa Days after infection Fusion index (
Uninfected ce
RAW264.7 50 5 3.0
MM6 50 3 2.3
Human blood monocytes 1 11 1.1
a MOI =multiplicity of infection (number of mycobacteria per number of monocyteswith much higher numbers of nuclei were present in the
LPS/IFN-γ-activated cells as well as in cells infected with
BCG (pAS-MDP1). The highest number of nuclei per
cell was found in cells infected with BCG (pAS-MDP1)
with 13 nuclei per fused macrophage. From this illustra-
tion it is obvious that the fusion rates of strain BCG
(pMV261) were more similar to those of uninfected
cells, while the fusion rates of strain BCG (pAS-MDP1)
resembled more those of cells activated with LPS and
IFN-γ.
Discussion
A large number of different functions have been pro-
posed for the MDP1 protein from M. bovis BCG, but its
role in infection has not been fully elucidated so far. To
better understand its role in infection, we investigated
its influence in very early stages of infection, and gaveter infection with BCG (pMV261) and BCG (pAS-MDP1)
FI) [%]





Figure 5 Morphology of multi-nucleated cells. Human blood monocytes (A), MM6 cells (B) and RAW264.7 cells (C) were infected with BCG
(pAS-MDP1) and stained with Diff-Quick. Micrographs were taken with a magnification of 400 × .
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derived immune cells. Our studies were performed with
a BCG strain down-regulated with respect to expression
of MDP1 by antisense-technique [BCG (pAS-MDP1)]
and a control strain containing the empty vector without
antisense-construct [BCG (pMV261)]. By using BCG
(pMV261) as control, we have ensured that the tested
strain and the control strain only differ by the presence
of the antisense-sequence. Different reactions of the two
strains can therefore be attributed to the antisense-Figure 6 Number of nuclei in multi-nucleated RAW264.7 cells.
RAW264.7 cells were infected with BCG (pMV261) and BCG (pAS-
MDP1) at an MOI 50. Uninfected cells served as negative controls
and cells activated with LPS and IFN-γ served as positive controls.
Five days after infection the cells were stained with Diff-Quick, and
the nuclei per multi-nucleated cells were counted and the fusion
indexes calculated.sequence. This is supported by our experiments with
other BCG genes and antisense-sequences also cloned
into pMV261, which generated different results depending
on the inserted sequence (data not shown). It therefore
can be concluded that the inserted sequences and not the
vector or additional RNA accumulation are responsible
for the differing phenotypes of control and test strains.
When mycobacteria are ingested into and reside in
macrophages, they are exposed to an environment char-
acterised by decreasing pH from around 6.4 in resting
macrophages to around 5.2 in activated macrophages
and below 5.0 in phagolysosomes [30-33]. Accordingly
we started by investigating the resistance to low pH of
our two strains. The growth was monitored in broth
adjusted to either pH 7 or 5.3, the latter corresponding
to the pH present in activated macrophages. Although
BCG (pAS-MDP1) grew better at pH 7 than BCG
(pMV261), the reduction of the MDP1 protein caused
an inability of these mycobacteria to adapt to low pH,
resulting in complete absence of growth at pH 5.3
(Figure 1C, D).
This remarkable sensitivity towards low pH of BCG
down-regulated in MDP1 expression might be an obs-
tacle for an intra-phagosomal lifestyle, and we conse-
quently investigated intracellular growth of the two
strains in human blood-derived monocytes. We quanti-
fied intracellular BCG by real-time PCR, because we
found this method more precise than colony counting.
On the one hand, DNA quantification is not that much
affected by clumping of BCG and presence of viable but
non-culturable cells, on the other hand this method
bears the risk of including dead bacteria. In a study of
Barrera and colleagues [34], it was, however, shown that
quantification of growth of intracellular BCG within
macrophages during four days by a PCR method yielded
results equivalent to those obtained by cfu counting or
measurement of uracil incorporation. Again, the BCG
(pAS-MDP1) showed no growth while BCG (pMV261)
was able to multiply inside the monocytes (Figure 2).
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perhaps by enabling the bacteria to adapt to conditions
present in the phagosomes such as low pH. Further
experiments such as blocking of phagosome acidifica-
tion or investigation of the presence and function of
vATPase in the phagosome membrane are required to
confirm a functional relationship between the influence
of MDP1 on low pH tolerance and intracellular replica-
tion. In previous experiments, using cell lines (J774A.1
and MM6) instead of primary blood cells, we had made
observations diverging from the results reported in this
study. In those cell lines the MDP1-down-regulated
strain showed better growth than the control strain
[27]. There are several possible explanations for the dif-
ferent outcomes of infections of the cell lines versus
blood monocytes. One plausible explanation is that pri-
mary monocytes on the one hand and cell lines on the
other hand dispose of very different properties. It was
shown that cell lines such as MM6, U-937 or THP-1
correspond to immature monocytes expressing bio-
chemical markers characteristic of immature cells in
monocyte development, which are not expressed by per-
ipheral blood monocytes. Correspondingly, markers
expressed at high levels in mature monocytes (e.g. lyso-
zyme, CD14, MHC class II) were not expressed or
expressed at low levels in these cell lines [35]. Deregula-
tion of immune signalling may also occur in cell lines.
The cell line J774A.1, for instance, continuously synthe-
sizes IL-1β (ATTC product description). Such proper-
ties may affect the mycobactericidal activity of cell lines
compared to primary blood monocytes. In contrast to
the cell line cultures which consisted of only one cell
type, namely the MM6 or J774A.1 cells, our blood
monocyte preparations which were purified by Ficoll/
Percoll gradient centrifugation contained about 70%
monocytes and about 30% CD14-negative cells (data
not shown). The latter fraction contained cells such as
CD4-positive IFN-γ-secreting lymphocytes able to acti-
vate monocytes. An activation of the primary monocytes
by IFN-γ-producing cells may have intensified the bac-
tericidal activity of blood-derived monocytes compared
to the cell lines.
Infection with M. bovis BCG (pAS-MDP1) caused a
lesser activation of PBMC than infection with BCG
(pMV261), as is evident from the cytokine expression of
infected PBMC: 24 hours after infection the pro-
inflammatory cytokine IL1-β was secreted at signifi-
cantly lower amounts upon infection with the
antisense-strain (Figure 3). IFN-γ as well as the anti-
inflammatory cytokine IL-10 were also secreted at lower
amounts, but due to donor variation no significance was
obtained for the latter cytokines if the mean of all
donors was calculated. The expression of these cyto-
kines is mediated via binding of pathogen molecules toToll-like receptors (TLR) located on the plasma and/or
phagosome membranes. Among the TLR, TLR2, TLR9
and TLR4 are responsible for recognising M. tubercu-
losis. TLR4 is activated by heat shock proteins 60/65
[36,37]. The heterodimers TLR2/TLR1 and TLR2/TLR6
can recognise mycobacterial lipoproteins. TLR2/TLR1
also bind mycobacterial cell wall glycolipids including
lipoarabinomannan, lipomannan and phosphatidylinosi-
tol mannoside [38] and a role of MDP1 in cell wall syn-
thesis has been proposed by Katsube et al. [10]. CpG
containing DNA represents the ligand of TLR9 [39]. An
influence of MDP1 on TLR9 signalling has been shown
by Matsumoto [40] who proved that addition of MDP1
protein to CpG DNA enhances the TLR9-dependent
immune stimulation of this DNA resulting in increased
synthesis of pro-inflammatory cytokines. The latter find-
ing is in line with our observation of reduced synthesis of
pro-inflammatory cytokines after infection with the
MDP1 down-regulated BCG. In addition to TLR, the cyto-
solic nucleotide-binding and oligomerisation domain-like
receptors such as NOD1 and NOD2 are able to bind
pathogen ligands and activate cytokine expression through
NF-κB. Signalling through NOD2 seems to require intra-
cellular metabolically active bacteria [39]. Therefore,
reduced cytokine secretion upon infection with the
MDP1-antisense-strain may also be related to the reduced
intracellular growth of this strain.
The interplay of cytokines secreted upon infection
with Mycobacterium effects an attraction of immune
cells to the site of infection, finally ending in the forma-
tion of granuloma. Multi-nucleated macrophages [multi-
nucleated giant cells (MGC) also called Langhans cells]
resulting from macrophage fusion reside in the middle
of these structures and are considered to be hallmarks of
granuloma. MGC are unable to phagocytose additional
mycobacteria due to decreased expression of phagocyt-
osis receptors. Their role seems to be to destroy myco-
bacteria that have been ingested by less differentiated
macrophages and monocytes and to present mycobacter-
ial antigens [41]. Lay et al. [41] showed that the maximal
number of nuclei per fused macrophage depended on
the infecting mycobacterial species, although all tested
mycobacteria were able to induce granuloma formation.
M. tuberculosis was able to induce MGC containing 15
and more nuclei per cell, while less pathogenic or oppor-
tunistic mycobacteria such as M. bovis BCG, M. microti,
M. avium, M. kansasii, M. smegmatis or M. phlei only
induced the formation of multi-nucleated cells contain-
ing up to seven nuclei per cell. We therefore wanted to
find out whether MDP1 played a role in fusion of
infected macrophages and had an influence on the dif-
ferentiation of macrophages. Our experiments showed
that in all cell types tested, including human blood
monocytes as well as cell lines such as MM6 and
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much higher rate of macrophage fusion (Table 1). In
RAW264.7, for example, we counted up to eight nuclei
per fused cell upon infection with BCG containing the
empty vector pMV261 (Figure 6). This result is very
similar to the results of Lay et al. [41] who reported that
BCG-infected human macrophages contained up to
seven nuclei per fused cell. When we infected
RAW264.7 with BCG (pAS-MDP1), we observed up to
13 nuclei per cell, which is close to the 15 nuclei per cell
reported by Lay et al. [41] to occur upon infection of
human cells with virulent M. tuberculosis. Lay and col-
leagues have related lack of the chromosomal regions in-
cluding the RD1 region in M. bovis BCG and M. microti
compared to M. tuberculosis to their reduced MGC-
inducing ability. Our results clearly show that MDP1
also plays a role in MGC formation.
Conclusion
Multiple functions have been assigned to the MDP1
protein, but its precise role during the infection process
has yet to be determined. We have investigated the in-
fluence of MDP1 on early events of infection. MDP1
was revealed to be crucial for adaptation to low pH,
intracellular multiplication, induction of cytokine secre-
tion and induction of macrophage fusion with gener-
ation of multi-nucleated Langhans cells. The latter
being the hallmark of granuloma and chronic infection,
our results support an important role of MDP1 in per-
sistent infection.
Methods
Bacterial strains, media and growth conditions
The construction of the BCG Copenhagen strain BCG
(pAS-MDP1) as well as the reference strain BCG
(pMV261) has been described in Lewin et al. [27]. The
plasmid pAS-MDP1 contains a 113 bp fragment of
BCG-DNA, covering the first 102 bp of the coding se-
quence from the MDP1 gene and 11 bp of the untrans-
lated upstream region with the Shine-Dalgarno
sequence. The fragment was inserted into the vector
pMV261 [42] downstream from the hsp60-promoter in
antisense-orientation. If compared to BCG containing
the empty vector pMV261 the expression of MDP1 is
reduced by about 50% in BCG (pAS-MDP1) grown in
broth culture [27]. Media and growth conditions have
been described before [27].
Cell lines and blood cells
The mouse macrophage cell line RAW264.7 (ATCC no
TIB-71™) was maintained by passaging twice weekly in
RPMI medium (GibcoW) supplemented with 10% FCS
(foetal calf serum) (Biochrom). Cultivation of cells was
performed in FalconTM 75 cm2 flasks at 37°C and with5% CO2. The human macrophage cell line Mono Mac
6 (MM6, DSMZ no ACC 124) was maintained in
RPMI medium supplemented with 10% FCS, 2 mM of
L-glutamine (PAA), non-essential amino acids (PAA)
and 1 mM of sodium pyruvate (PAA) and passaged
twice a week. PBMC and blood monocytes were isolated
from buffy coats from healthy, female, anonymous
donors. Buffy coats were supplied by the German Red
Cross which previously had obtained the donors’ con-
sent for use of their blood donation for scientific pur-
poses. PBMC were isolated by Ficoll-PaqueTM Plus (GE
Healthcare) gradient centrifugation according to the
manufacturer’s recommendations. After the Ficoll gradi-
ent centrifugation, the PBMC were washed twice with
PBS (140 mM of NaCl, 16 mM of Na2HPO4, 2 mM of
KH2PO4, 3.75 mM of KCl, pH 7.4) and resuspended in
IMDM medium (PAA) with 3% human AB serum
(PAA). For isolation of blood monocytes, a gradient
centrifugation with PercollTM (GE Healthcare) was per-
formed directly after the Ficoll gradient centrifugation.
The monocytes were then washed twice with PBS and
resuspended in IMDM medium with 3% human AB
serum. To further enrich monocytes, the cells were
allowed to adhere overnight and non-adherent cells
were removed by rinsing. The percentage of monocytes
was evaluated by quantification of the CD14+ popula-
tion by FACS analysis using a mouse anti-human CD14
antibody (monoclonal antibody MEM-18, Immuno
Tools) and a goat anti-mouse FITC-conjugated second-
ary antibody (Immuno Tools). A mouse IgG1 control
(monoclonal antibody 203, Immuno Tools) was
included to assess non-specific antibody binding. FACS
analysis was performed using the BD FACSCalibur cyt-
ometer (BD Biosciences) and identified ~70% of the cell
preparation as monocytes.Measurement of pH-resistance
Comparison of the growth rates of M. bovis BCG (pAS-
MDP1) and M. bovis BCG (pMV2161) was carried out
by inoculating Middlebrook 7H9 medium (pH 7) as well
as 7H9 medium adjusted to pH 5.3, both containing 10%
OADC and 25 μg ml-1 of Kanamycin. To prepare the
acidic medium, we first dissolved 7H9 powder in water,
then adjusted the pH to 5.3 with HCl, filter-sterilised the
medium and finally added 10% OADC. Pre-cultures of
both strains were first grown in Middlebrook 7H9
medium (pH 7) with 10% OADC to an OD [600 nm] of
3, and aliquots of these pre-cultures were inoculated into
pH-adjusted media to obtain an initial OD of 0.02 to
0.04. Growth of the strains was monitored during 42 days
by OD measurement and ATP quantification using the
BacTiter-GloTM Microbial Cell Viability Assay Kit (Pro-
mega) as described in Lewin et al. [43]. This kit
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terial cells.Measurement of cytokine secretion by infected PBMC
One million (mio) PBMC per 500 μl of IMDM with 3%
human AB serum were seeded into 24-well plates
(Techno Plastic Products AG) together with 1 mio
mycobacteria grown to OD 3. After 24 hours the super-
natants were removed and frozen at −20°C until the
quantification of the amounts of IFN-γ, IL-1β, IL-10 and
TNF-α was performed by ELISA with the Ready-SET-Go
kits from eBioscience. Negative controls consisted of un-
infected PBMC. Positive controls consisted of PBMC
that had been activated by addition of 10 ng ml-1 of LPS
(from E. coli, Sigma Aldrich) and 100 U of IFN-γ
(eBioscience).Measurement of intracellular persistence of BCG-
derivatives in human blood monocytes
After isolation of human blood monocytes by Ficoll/Per-
coll gradient centrifugation, 1 mio cells in 1 ml of
IMDM with 3% human AB serum were seeded into the
wells of 24-well plates and allowed to adhere overnight.
Non-adherent cells were then removed by rinsing and
fresh medium was added to the adherent cells. Infection
took place after 15 hours. BCG-strains grown to OD 2
were added at an MOI of 1, and the plates were centri-
fuged at 400 g for 5 min. After an infection time of four
hours, extracellular BCG were removed by washing
twice with IMDM and extracellular bacteria still present
were killed by incubation in IMDM with 3% human AB
serum and 200 μg ml-1 of Amikacin for two hours. The
cells were then again washed twice and incubated for
the rest of the experiment in medium containing
2 μg ml-1 of Amikacin. Samples for quantification of
intracellular bacteria were taken four hours after
addition of the bacteria (initial infection rate) and then
every 24 hours during five days. Samples were taken by
removing the supernatants, adding of 500 μl of water to
the wells and incubating the plates for 15 min at 37°C
for lysis of the macrophages and release of intracellular
mycobacteria. The lysates were stored at −20°C. DNA
was isolated from the lysates as described before [43].
We then quantified the BCG DNA as described in [43]
by TaqMan-PCR amplifying a fragment of 130 bp from
the 85B antigen gene using the primers MY85B FW/BW
(5’-TCAGGGGATGGGGCCTAG-3′ and 5′-GCTTGGG
GATCTGCTGCGTA-3′; [44]) and the dually labelled
detector probe 5′-(FAM)-TCGAGTGACCCGGCATGG
GAGCGT-3′-(TAMRA) [45]. The primers and the probe
are specific for mycobacteria. The amount of DNA was
determined by means of a standard established with
known amounts of genomic BCG DNA and convertedinto bacterial numbers on the basis of the molecular
weight of one BCG genome.
Measurement of fusion rates of infected macrophage cell
lines and blood monocytes
The induction of the fusion of macrophages by infection
with the BCG-derivatives was investigated with the
mouse macrophage line RAW264.7, the human macro-
phage line MM6 and monocytes isolated from human
blood. The human monocytes were infected at an MOI
of only 1, because they reacted more sensitive to BCG
compared to the cell lines, which very well tolerated an
infection at an MOI 50. 24-well plates were loaded with
glass cover slips that had been treated as follows: the
cover slips were incubated overnight in 250 ml of H2O
with 0.5 ml of 100% acetic acid. After rinsing twice with
water, they were rinsed with 95% methanol, dried at 37°C
overnight and autoclaved.
5 × 104 RAW264.7 cells in 1 ml of RPMI medium with
10% FCS were infected with 2.5 × 106 BCG cells (MOI
50). The plates were centrifuged for 5 min at 400 g and
incubated for four hours. Removal and killing of extra-
cellular bacteria was performed as described above. After
five days the cells were stained as described below.
Human blood monocytes were isolated as described
above, 1 × 106 monocytes were infected with 1 × 106
BCG (MOI 1) for four hours, and extracellular bacteria
were removed and killed as described. Staining of the
cells was performed three, four and 11 days after
infection.
A different procedure had to be followed for determin-
ation of the fusion rates of MM6 cells, because these
cells grow in suspension. 5 × 106 MM6 cells together
with 2.5 × 108 BCG (MOI 50) were mixed in 5 ml of
RPMI with 10% FCS in Falcon tubes and incubated at
37°C and 5% CO2 for four hours. The tubes were gently
shaken in between. Then, 35 ml of RPMI with 10% FCS
were added and the tubes were centrifuged at 600 rpm
for 10 min. The pellets were resuspended in 40 ml of
RPMI with 10% FCS and centrifuged again. The bacteria
were then resuspended in 30 ml of MM6 medium, and
200 μg ml-1 of Amikacin were added for two hours to
kill extracellular mycobacteria. The cells were centri-
fuged as above, resuspended in 30 ml of RPMI with 10
FCS, centrifuged again and the pellets were finally resus-
pended in 10 ml of MM6 medium. 2 × 105 cells in 1 ml
of MM6 medium with 3 μg ml-1 of Amikacin were given
into the wells with the cover slips. For negative controls,
all three types of macrophages were incubated without
bacteria. Positive controls consisted of uninfected
macrophages activated with 100 U of IFN-γ (human
IFN-γ: eBioscience; mouse- IFN-γ: Invitrogen) and
10 ng ml-1 of LPS (Sigma). Staining of the monocytes to
visualise the nuclei was performed with the Diff Quick
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were evaluated by microscopy (Zeiss Axioskop 40),
photographed (Axiocam HRc, Axiovision Rel.4.8.2), and
the numbers of nuclei per monocyte were counted.
Macrophages containing at least three nuclei were con-
sidered as multi-nucleated. At least 1000 nuclei were
counted per preparation and the number of nuclei
present in multi-nucleated cells was determined. The fu-
sion index (FI) was calculated using the formula:
FI %½  ¼ number of nuclei in multi nucleated cells
total number of nuclei
 100
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